GENEVA, Aug. 14 -- PFIZER INC. filed a patent application (IB2026/050982) for “SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS AS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1 R) AGONISTS”. With publication no. WO/2026/167526, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 413/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....